The effect of PCSK9 inhibitors on cardiovascular outcomes in diabetic patients: a narrative review.

Leqvio (inclisiran) - Novartis

http://www.ncbi.nlm.nih.gov/pubmed/42564055

Abdullah Hussain; Abu-Baker Khalid Sharafeldin; Ahmed J AlAraibi; Alexandra E Butler; Noor Elhuda Taher Aljundi

Aug 8, 2026